Clinical Trial Update: Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A prospective Phase 2 trial of cabazitaxel in temozolomide-refractory glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: University of Ulm | Conditions: Glioblastoma Multiforme (GBM) WHO Grade IV | Phase 2 | Status: COMPLETED